Une intervention d'Elisa Vecchione dans le cadre d'un panel (panel 17, "What a Role for CBA in the European Union?") organisé à l'occasion de la 4e conférence annuelle de la Society for Benefit-Cost Analysis, "Expanding the Scope of Benefit Cost Analysis: Practical Applications and Analytical Frontiers".

L'organisation de ce panel s'inscrit dans le cadre du projet SustainableRIO.

Présentation de la conférence [en anglais] :

This year, our Fourth Annual Conference and Meeting will continue the focus of past conferences on the practical use of Benefit-Cost Analysis (BCA) in a variety of institutional and national settings, with special attention to the role of BCA in both prospective and retrospective program evaluation; and to broadening and improving measurement of benefits and/or costs. As in past years, the conference will convene a large number of guests, including researchers, and practitioners working in academia, nonprofits, businesses, and government around the world."

Présentation du panel [en anglais] :

"At a time of growing international interest and policy diffusion of cost benefit analysis (CBA), this panel explores how CBA is gradually finding its way in the European Union. The American "good government" project has its counterpart in the European "better regulation" initiative, issued in 2002 to pursue the same idea of rationalizing regulatory decision-making. Though nobody would contest that rationalization is desirable, its application to regulatory policymaking is not undisputed, even more so if regulation targets sensitive areas such as consumers’ health and the environment. These problems have their main origin in the institutional combination of powers that is specific to the United States and the European Union and that gives regulatory rationalization a different quality to the two actors.

It is against this backdrop that the panel proposes to explore the institutional adaptability of CBA to European rule-making. On the one hand, an instructive comparison between OIRA and its EU counterpart, the European Impact Assessment Board, will be provided to highlight the successes and failures of the EU regulatory reform efforts in the light of the US experience. On the other, a more theoretical debate will be opened on the use of CBA for promoting “evidence-based” regulation and, by virtue of this, enhancing international convergence on highly national matters such as the regulation of collective risks. In this spirit, the panel will also consider identifying opportunities to learn from other’s policy innovations, and examine options for increasing international cooperation in evaluating and improving the quality of each nation’s policies and laws."

>> En savoir plus